These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30660586)

  • 41. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Routine monitoring of gentamicin serum concentrations in pediatric patients with normal renal function is unnecessary.
    Logsdon BA; Phelps SJ
    Ann Pharmacother; 1997 Dec; 31(12):1514-8. PubMed ID: 9416390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacokinetics and pharmacodynamics of isepamicin.
    Tod M; Padoin C; Petitjean O
    Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels.
    Hansen A; Forbes P; Arnold A; O'Rourke E
    J Perinatol; 2003 Dec; 23(8):635-9. PubMed ID: 14647159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
    Bouglé A; Dujardin O; Lepère V; Ait Hamou N; Vidal C; Lebreton G; Salem JE; El-Helali N; Petijean G; Amour J
    Anaesth Crit Care Pain Med; 2019 Oct; 38(5):493-497. PubMed ID: 30831307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
    Marik PE; Havlik I; Monteagudo FS; Lipman J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Surveillance of therapy with aminoglycosides at a specialized hospital].
    Macías-Hernández AE; León-Hernández AC; Muñoz-Barrett JM; Olivares-Durán EM; Aguilar-Orozco G; Córdova-Rodríguez C
    Rev Invest Clin; 1993; 45(4):339-43. PubMed ID: 8235135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicenter quality control study of amikacin assay for monitoring once-daily dosing regimens. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Blaser J; König C; Fatio R; Follath F; Cometta A; Glauser M
    Ther Drug Monit; 1995 Apr; 17(2):133-6. PubMed ID: 7624900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity.
    Yamada T; Fujii S; Shigemi A; Takesue Y
    J Infect Chemother; 2021 Feb; 27(2):256-261. PubMed ID: 33077364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amikacin population pharmacokinetics among paediatric burn patients.
    Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
    Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems.
    Bouzas L; Hermida J; Tutor JC
    Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
    Sridharan K; Al Daylami A
    J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate.
    Gilbert DN; Lee BL; Dworkin RJ; Leggett JL; Chambers HF; Modin G; Täuber MG; Sande MA
    Am J Med; 1998 Sep; 105(3):182-91. PubMed ID: 9753020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
    Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
    van Maarseveen EM; Sprij A; Touw DJ
    Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
    Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV
    J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.